Bloomberg [1] |
AstraZeneca Fails to Win FDA Backing for Diabetes Treatment [1]
Bloomberg AstraZeneca Plc failed to win U.S. approval for a new diabetes treatment [2] that combines two of its existing drugs after regulators asked for additional data that may require new clinical trials. The drugmaker will work closely with the Food and Drug … FDA asks for more clinical trials to AstraZeneca diabetes treatment [3]Pulse Headlines FDA Holds Off Approval Of AstraZeneca Diabetes Treatment [4]Law360 (subscription) FDA declines approval of AZN's diabetes treatment [5]Seeking Alpha StreetInsider.com [6] all 98 news articles » [7] |
More details can be found at www.diabeteshowto.com [8]